Pharmacist-led intervention to reduce heart disease risk
Implementation of Pharmacist Case Finding and Intervention for Vascular Prevention (PRxOACT) Study
This study tests if working with pharmacists can help adults lower their risk of heart disease by giving them personalized health support.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 982 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT06405880 on ClinicalTrials.gov |
What this trial studies
This project investigates the effectiveness of a pharmacist-led care pathway aimed at reducing cardiovascular risk factors among adults. By leveraging the frequent interactions patients have with pharmacists, the study seeks to empower individuals to manage their health better and lower their risk of heart disease. Participants will receive tailored interventions based on their specific health conditions, such as diabetes or hypertension, to improve their overall cardiovascular health.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a clinical diagnosis of conditions like diabetes, hypertension, or obesity.
Not a fit: Patients who are pregnant or unwilling to participate in follow-up visits may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly lower the incidence of heart disease and improve patient health outcomes.
How similar studies have performed: Other studies have shown that pharmacist-led interventions can effectively improve health outcomes in patients with cardiovascular risk factors, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (18 years or older) * Clinical diagnosis of at least one of the following conditions: * Diabetes, * Chronic kidney disease, * Chronic inflammatory condition (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, systemic lupus erythematosus or psoriasis), * Atherosclerotic vascular disease, * Hypertension, * Obesity (defined as body mass index greater than 30), * Current tobacco or vape use Exclusion Criteria: * Unwilling to participate/sign consent form; * Unwilling or unable to participate in regular follow-up visits; or * Pregnant
Where this trial is running
Edmonton, Alberta
- The University of Alberta — Edmonton, Alberta, Canada (Recruiting)
Study contacts
- Principal investigator: Yazid Al Hamarneh — University of Alberta
- Study coordinator: Yazid Al Hamarneh
- Email: yazid.alhamarneh@ualberta.ca
- Phone: 780-492-9608
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.